Rwanda vs Thailand: Cause of death, by non-communicable diseases, ages 60+, male
Rwanda
69.0%
in 2021
Thailand
68.6%
in 2021
Rwanda rank
92nd
Thailand rank
94th
Cause of death, by non-communicable diseases, ages 60+, male over time
- Rwanda
- Thailand
How they compare
Rwanda currently reports 69.0% against 68.6% in Thailand, a difference of 0.4%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Thailand ahead.
Rwanda ranks 92nd and Thailand ranks 94th of 185 countries.
Thailand has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Rwanda | Thailand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 69.8% | 75.7% | 5.9% | Thailand |
| 2010s | 72.4% | 80.6% | 8.2% | Thailand |
| 2020s | 71.4% | 74.1% | 2.7% | Thailand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Rwanda or Thailand?
- Rwanda, at 69.0% against 68.6% in Thailand as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Rwanda and Thailand?
- 0.4%, with Rwanda ahead.
- How many years of comparable data are there for Rwanda and Thailand?
- 6 years are reported by both, from 2000 to 2021.
- How do Rwanda and Thailand rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Rwanda ranks 92nd and Thailand ranks 94th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.